A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors
Clinical trial NCT02014909 · COMPLETED
Trial details
- NCT number
- NCT02014909
- Sponsor
- Celldex Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2017-05-25
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.